AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Tenax Therapeutics, Inc.
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001S78GM3
1.72▼ 0.04 (-2.27%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.76
Day's Range
1.69 – 1.76
52-Week Range
1.31 – 19.40
Volume
852.0K
Avg Volume
2.4M
Share Statistics
Shares Outstanding
Employees
16
Exchange
XNAS
Listed
1995-02-01
Share count as of July 28, 2026

Tenax Therapeutics, Inc. (TENX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Tenax Therapeutics, Inc. (TENX)
What is Tenax Therapeutics, Inc.'s Market Cap?
Tenax Therapeutics, Inc.'s Market Cap is $64.4M, based on as-reported figures from SEC (XBRL) filings.
What is Tenax Therapeutics, Inc.'s Revenue (TTM)?
Tenax Therapeutics, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Tenax Therapeutics, Inc.'s Net Income (TTM)?
Tenax Therapeutics, Inc.'s Net Income (TTM) is -$64.9M, based on as-reported figures from SEC (XBRL) filings.
What is Tenax Therapeutics, Inc.'s Diluted EPS (TTM)?
Tenax Therapeutics, Inc.'s Diluted EPS (TTM) is -1.73, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TENXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses
Research and development
Selling, general and administrative———
Total operating expenses
Net operating loss
Interest income
Other expense, net
Net loss
Net loss per share, basic
Net loss per share, diluted